<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from the Condensed Consolidated Financial Statements of BioMarine Technologies, Inc. and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> JUN-30-2000 <CASH> 32,696 <SECURITIES> 1,262 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 32,696 <PP&E> 37,849 <DEPRECIATION> 124,821 <TOTAL-ASSETS> 72,832 <CURRENT-LIABILITIES> 438,446 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 26,131 <OTHER-SE> (391,747) <TOTAL-LIABILITY-AND-EQUITY> 72,832 <SALES> 0 <TOTAL-REVENUES> 50,000 <CGS> 0 <TOTAL-COSTS> 253,744 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 17,307 <INCOME-PRETAX> (203,744) <INCOME-TAX> 0 <INCOME-CONTINUING> (203,744) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (203,744) <EPS-BASIC> (0.09) <EPS-DILUTED> (0.09)